Search clinical trials for: PKC412
Total 34 results
-
Novartis PharmaceuticalsRecruitingFLT3-mutated Acute Myeloid LeukemiaKorea, Republic of, Germany, Italy, Turkey, Czechia, Jordan, Slovenia, Austria, Poland, Japan, Russian Federation, United States, Greece
-
Novartis PharmaceuticalsCompletedAcute Myeloid LeukemiaJapan, Taiwan, Hong Kong, Thailand, Korea, Republic of, Russian Federation, Vietnam
-
Novartis PharmaceuticalsNo longer availableAcute Myeloid Leukemia (AML) With | FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)United States
-
University Medical Center GroningenUnknown
-
Novartis PharmaceuticalsAvailableAcute Myeloid Leukemia | Mast Cell Leukemia | Aggressive Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematologic Neoplasm | FMS-Like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia
-
Novartis PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Canada
-
Jason Robert GotlibNovartis; Novartis PharmaceuticalsCompletedSystemic Mastocytosis, Aggressive (ASM) | Leukemia, Mast Cell | Hematological Non-mast Cell Lineage Disease (AHNMD)United States
-
Alison WalkerNovartis; Millennium Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid... and other conditionsUnited States
-
Novartis PharmaceuticalsTerminatedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaSweden, Italy, France, United States, Netherlands
-
University of KansasNovartisCompletedAcute Myeloid LeukemiaUnited States
-
Braintree LaboratoriesCompletedColonoscopyUnited States
-
Novartis PharmaceuticalsCompletedAcute Myeloid LeukemiaItaly, Croatia, Estonia, Czechia, France, Spain, Sweden, Bulgaria, Lithuania, Serbia, Hungary, Finland, Norway, Romania, Slovakia
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia (AML)United States, Spain, Belgium, Germany, Japan, Taiwan, Turkey, Italy, Australia, Austria, Switzerland, Israel, Bulgaria, France, Norway, Brazil, Poland, Portugal, Czechia, Argentina
-
University of FloridaNovartis PharmaceuticalsWithdrawnAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNovartis Pharmaceuticals; Celgene CorporationCompleted
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
Novartis PharmaceuticalsNo longer availableFLT3-mutated Acute Myeloid LeukemiaCanada
-
Uma BorateRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Richard Stone, MDMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalActive, not recruitingRAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome/Acute Myeloid LeukemiaUnited States
-
Brenda Cooper, MDNational Cancer Institute (NCI)CompletedUntreated Adult Acute Myeloid LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedHepatic ImpairmentGermany, Belgium, Lithuania, United States, Bulgaria, Romania
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia (AML)United States, Germany
-
University of UlmNovartis PharmaceuticalsCompleted
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedSecondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Acute Myeloid Leukemia With Gene Mutations | FLT3 Tyrosine Kinase Domain Point MutationUnited States
-
David IberriTerminatedAcute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults | AML (Adult) With 11q23 (MLL) Abnormalities | AML (Adult) With Del (5q) | AML (Adult) With Inv (16) (p13; q22) | AML (Adult) With t (16;16) (p13; q22) | AML (Adult) With t (8; 21) (q22; q22) and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Sanwa Kagaku Kenkyusho Co., Ltd.Completed
-
Washington University School of MedicineCompletedLeukemia, Myeloid, AcuteUnited States
-
Massachusetts General HospitalCompleted
-
Novartis PharmaceuticalsCompletedLeukemiaUnited States, Belgium, Netherlands, Canada, Austria, Germany, Australia, United Kingdom, Turkey, France, Poland, Norway
-
Technische Universität DresdenNovartis PharmaceuticalsCompletedAcute Myeloid LeukemiaGermany
-
Novartis PharmaceuticalsWithdrawnLeukemia, Myeloid, Acute